Probable predictive biomarkers for tumor response to mTOR inhibitors, as have been explained in glioblastoma, breast and prostate cancer cells, may be the differential expression of mTOR pathway proteins, PTEN, AKT, and S6.[one] Hence, this info is based on preclinical assays, dependant on in vitro cultured tumor mobile lines, which suggest that th… Read More